Somite

Somite.ai is a venture capital-backed company aiming to become the OpenAI of stem cell biology. It develops artificial intelligence foundational models for the large-scale production of human tissues in cell therapies targeting diseases such as diabetes, obesity, and muscular dystrophy. Somite's AI platform, AlphaStem, drives a virtuous cycle: the platform supports new cell therapies, and the vast amounts of data generated further enhance the platform, enabling faster development of therapies with broader applications.